Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report

Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report

Abstract Background Tocilizumab has been shown to be effective for treatment of juvenile idiopathic arthritis (JIA). To our knowledge, this is the first reported case of interstitial lung disease occurring shortly after tocilizumab infusion in a patient with JIA. Case presentation A 14-year-old fema...

Full description

Bibliographic Details
Main Authors: Koichi Sugihara, Risa Wakiya, Hiromi Shimada, Mikiya Kato, Tomohiro Kameda, Shusaku Nakashima, Mai Mahmoud Fahmy Mansour, Yusuke Ushio, Norimitsu Kadowaki, Hiroaki Dobashi
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Juvenile idiopathic arthritis
Drug-induced interstitial lung disease
Tocilizumab
Interleukin-6
Online Access:https://doi.org/10.1186/s13223-021-00594-7

Internet

https://doi.org/10.1186/s13223-021-00594-7

Similar Items